Vertex Pharmaceuticals (VRTX) Prepaid Assets (2009 - 2026)
Vertex Pharmaceuticals' quarterly Prepaid Assets came in at $720.8 million in Q1 2026, up 12.13% year-on-year from $642.8 million in Q1 2025, and down 15.53% quarter-over-quarter from $853.3 million in Q4 2025.
Vertex Pharmaceuticals has reported Prepaid Assets for 18 years, with the latest figure at $720.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 12.13% year-over-year to $720.8 million; the trailing twelve-month figure through Mar 2026 stood at $720.8 million (up 12.13% YoY), and the FY2025 full-year result was $853.3 million, up 1016.88% from the prior year.
- Prepaid Assets for Q1 2026 stood at $720.8 million, down from $853.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $853.3 million in Q4 2025, with the low at $74.4 million in Q4 2022.
- Average Prepaid Assets over 5 years is $506.1 million, with a median of $540.2 million recorded in 2023.
- Year-over-year, Prepaid Assets decreased 25.68% in 2023 and jumped 1016.88% in 2025.
- Tracing VRTX's Prepaid Assets over 5 years: stood at $74.4 million in 2022, then gained by 13.31% to $84.3 million in 2023, then decreased by 9.37% to $76.4 million in 2024, then jumped by 1016.88% to $853.3 million in 2025, then dropped by 15.53% to $720.8 million in 2026.
- The last three Prepaid Assets figures came in at $720.8 million (Q1 2026), $853.3 million (Q4 2025), and $709.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.80 Mn |
| Dec 31, 2025 | 853.30 Mn |
| Sep 30, 2025 | 709.40 Mn |
| Jun 30, 2025 | 652.30 Mn |
| Mar 31, 2025 | 642.80 Mn |
| Dec 31, 2024 | 76.40 Mn |
| Sep 30, 2024 | 449.20 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Mar 31, 2024 | 511.10 Mn |
| Dec 31, 2023 | 84.30 Mn |
| Sep 30, 2023 | 540.20 Mn |
| Jun 30, 2023 | 476.90 Mn |
| Mar 31, 2023 | 468.70 Mn |
| Dec 31, 2022 | 74.40 Mn |
| Sep 30, 2022 | 726.90 Mn |
| Jun 30, 2022 | 549.50 Mn |
| Mar 31, 2022 | 491.50 Mn |
| Dec 31, 2021 | 59.20 Mn |
| Sep 30, 2021 | 457.83 Mn |
| Jun 30, 2021 | 498.76 Mn |
| Mar 31, 2021 | 338.93 Mn |
| Dec 31, 2020 | 308.30 Mn |
| Sep 30, 2020 | 270.02 Mn |
| Jun 30, 2020 | 232.57 Mn |
| Mar 31, 2020 | 223.65 Mn |
| Dec 31, 2019 | 213.52 Mn |
| Sep 30, 2019 | 175.14 Mn |
| Jun 30, 2019 | 151.83 Mn |
| Mar 31, 2019 | 130.01 Mn |
| Dec 31, 2018 | 140.82 Mn |
| Sep 30, 2018 | 118.68 Mn |
| Jun 30, 2018 | 122.69 Mn |
| Mar 31, 2018 | 109.89 Mn |
| Dec 31, 2017 | 75.74 Mn |
| Sep 30, 2017 | 152.24 Mn |
| Jun 30, 2017 | 107.08 Mn |
| Mar 31, 2017 | 128.49 Mn |
| Dec 31, 2016 | 34.40 Mn |
| Sep 30, 2016 | 61.01 Mn |
| Jun 30, 2016 | 56.26 Mn |
| Mar 31, 2016 | 55.87 Mn |
| Dec 31, 2015 | 54.74 Mn |
| Sep 30, 2015 | 63.39 Mn |
| Jun 30, 2015 | 53.29 Mn |
| Mar 31, 2015 | 62.65 Mn |
| Dec 31, 2014 | 7.00 Mn |
| Sep 30, 2014 | 41.30 Mn |
| Jun 30, 2014 | 34.40 Mn |
| Mar 31, 2014 | 35.01 Mn |
| Dec 31, 2013 | 23.84 Mn |
| Sep 30, 2013 | 41.10 Mn |
| Jun 30, 2013 | 43.23 Mn |
| Mar 31, 2013 | 47.84 Mn |
| Dec 31, 2012 | 24.67 Mn |
| Sep 30, 2012 | 35.12 Mn |
| Jun 30, 2012 | 40.52 Mn |
| Mar 31, 2012 | 35.41 Mn |
| Dec 31, 2011 | 14.89 Mn |
| Sep 30, 2011 | 23.25 Mn |
| Jun 13, 2011 | 69,000.00 |
| Mar 31, 2011 | 26.11 Mn |
| Dec 31, 2010 | 13.10 Mn |
| Sep 30, 2010 | 18.46 Mn |
| Jun 30, 2010 | 21.86 Mn |
| Mar 31, 2010 | 26.21 Mn |
| Dec 31, 2009 | 12.51 Mn |